Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
about
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple SclerosisAnti-JC virus seroprevalence in a Finnish MS cohort.To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis.
P2860
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of natalizumab treatmen ...... ients with multiple sclerosis.
@ast
Effect of natalizumab treatmen ...... ients with multiple sclerosis.
@en
type
label
Effect of natalizumab treatmen ...... ients with multiple sclerosis.
@ast
Effect of natalizumab treatmen ...... ients with multiple sclerosis.
@en
prefLabel
Effect of natalizumab treatmen ...... ients with multiple sclerosis.
@ast
Effect of natalizumab treatmen ...... ients with multiple sclerosis.
@en
P2093
P2860
P1433
P1476
Effect of natalizumab treatmen ...... ients with multiple sclerosis.
@en
P2093
Julvet Mbianda
Katiana Francois
Pia Kivisäkk
Roopali Gandhi
Samia J Khoury
P2860
P304
P356
10.1371/JOURNAL.PONE.0103716
P407
P577
2014-07-30T00:00:00Z